Considering that SARS-CoV-2 might initiate inflammatory processes and induce ALI, HMGB1 could be used as a target for specific prevention and treatment option for pediatric COVID-19 and SARS-CoV-2-induced ALI. The gene discussed is HMGB1; the disease is acute respiratory distress syndrome.